Stryker Acquires NICO Corporation
September 20, 2024
Stryker has completed the acquisition of NICO Corporation, a privately held developer of minimally invasive neurosurgical systems including BrainPath and Myriad. The purchase expands Stryker's neurotechnology portfolio and strengthens its capabilities in tumor resection and treatment of intracerebral hemorrhage (stroke) worldwide.
- Buyers
- Stryker
- Targets
- NICO Corporation
- Industry
- Medical Devices
- Location
- Indiana, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Stryker Acquires Cerus Endovascular
May 2, 2023
Medical Devices
Stryker has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage medical device company that developed the Contour Neurovascular System and Neqstent devices for treatment of intracranial aneurysms. The deal expands Stryker’s Neurovascular portfolio and strengthens its aneurysm/hemorrhagic treatment capabilities globally (reported purchase price approximately $530 million).
-
Stryker Acquires Vertos Medical Inc.
August 22, 2024
Medical Devices
Stryker has entered into a definitive agreement to acquire Vertos Medical Inc., a privately held company that develops the minimally invasive Mild® procedure for treating lumbar spinal stenosis. The acquisition expands Stryker’s interventional pain management and minimally invasive treatment portfolio and extends its reach into ambulatory surgery centers; the transaction remains subject to customary closing conditions.
-
Stryker Completes Acquisition of MOLLI Surgical Inc.
July 31, 2024
Medical Devices
Stryker has completed the acquisition of MOLLI Surgical Inc., a privately held developer of wire-free soft tissue localization technology for breast-conserving surgery. The purchase brings MOLLI's MOLLI 2 localization system and small MOLLI Marker into Stryker's breast-cancer surgical portfolio, expanding its capabilities in oncology surgical solutions.
-
Boston Scientific Acquires Axonics, Inc.
November 15, 2024
Medical Devices
Boston Scientific Corporation agreed to and completed the acquisition of Axonics, Inc., a publicly traded medical technology company focused on sacral neuromodulation and urology devices, for $71 per share (approximately $3.7 billion equity value). The deal expands Boston Scientific’s urology portfolio by adding Axonics’ SNM therapy products and related technologies, expected to be accretive to its Urology business over time.
-
VB Spine Acquires Stryker’s Spinal Implants Business in Australia and New Zealand
July 31, 2025
Medical Devices
VB Spine LLC has completed the acquisition of Stryker’s spinal implants business in Australia and New Zealand. The deal marks VB Spine’s first market entry outside the United States; LifeHealthcare will remain the exclusive distributor across both countries, and Viscogliosi Brothers LLC and Viscogliosi Brothers Watermark LLC are equity investors in VB Spine.
-
Viscogliosi Brothers Acquires Stryker's U.S. Spine Business to Create VB Spine
April 1, 2025
Medical Devices
Viscogliosi Brothers, a New York–based family office, completed the acquisition of Stryker's U.S. spine business and will operate it as VB Spine, LLC. Financial partners Barings and Texas Capital Bank supported the transaction; VB Spine aims to grow the business, expand globally and retain access to Stryker technologies such as Mako Spine and Copilot.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.